Skip to content

Research at St Andrews

Symmetrical choline-derived dications display strong anti-kinetoplastid activity

Research output: Contribution to journalArticlepeer-review

DOI

Author(s)

Hasan M. S. Ibrahim, Mohammed I. Al-Salabi, Nasser El Sabbagh, Neils B. Quashie, Abdulsalam A. M. Alkhaldi, Roger Escale, Terry K. Smith, Henri J. Vial, Harry P. de Koning

School/Research organisations

Abstract

To investigate the anti-kinetoplastid activity of choline-derived analogues with previously reported antimalarial efficacy.

From an existing choline analogue library, seven antimalarial compounds, representative of the first-, second- and third-generation analogues previously developed, were assessed for activity against Trypanosoma and Leishmania spp. Using a variety of techniques, the effects of choline analogue exposure on the parasites were documented and a preliminary investigation of their mode of action was performed.

The activities of choline-derived compounds against Trypanosoma brucei and Leishmania mexicana were determined. The compounds displayed promising anti-kinetoplastid activity, particularly against T. brucei, to which 4/7 displayed submicromolar EC50 values for the wild-type strain. Low micromolar concentrations of most compounds cleared trypanosome cultures within 24-48 h. The compounds inhibit a choline transporter in Leishmania, but their entry may not depend only on this carrier; T. b. brucei lacks a choline carrier and the mode of uptake remains unclear. The compounds had no effect on the overall lipid composition of the cells, cell cycle progression or cyclic adenosine monophosphate production or short-term effects on intracellular calcium levels. However, several of the compounds, displayed pronounced effects on the mitochondrial membrane potential; this action was not associated with production of reactive oxygen species but rather with a slow rise of intracellular calcium levels and DNA fragmentation.

The choline analogues displayed strong activity against kinetoplastid parasites, particularly against T. b. brucei. In contrast to their antimalarial activity, they did not act on trypanosomes by disrupting choline salvage or phospholipid metabolism, instead disrupting mitochondrial function, leading to chromosomal fragmentation.

Close

Details

Original languageEnglish
Pages (from-to)111-125
Number of pages15
JournalJournal of Antimicrobial Chemotherapy
Volume66
Issue number1
DOIs
Publication statusPublished - Jan 2011

    Research areas

  • Trypanosoma brucei, leishmaniasis, protozoan parasite, lipid metabolism, choline, BLOOD-STREAM FORMS, TRYPANOSOMA-BRUCEI-BRUCEI, PROGRAMMED CELL-DEATH, PLASMODIUM PHOSPHOLIPID-METABOLISM, SUBSTRATE RECOGNITION MOTIFS, POTENT ANTIMALARIAL ACTIVITY, PURINE NUCLEOBASE TRANSPORT, AFRICAN TRYPANOSOMES, INFECTED ERYTHROCYTES, DRUG-RESISTANCE

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Turnover of variant surface glycoprotein in Trypanosoma brucei is a bimodal process

    Garrison, P., Khan, U., Cipriano, M., Bush, P. J., McDonald, J., Sur, A., Myler, P. J., Smith, T. K., Hajduk, S. L. & Bangs, J. D., Aug 2021, In: mBio. 12, 4, 12 p., e01725-21.

    Research output: Contribution to journalArticlepeer-review

  2. A brief journey into the history of, and future sources and uses of fatty acids

    Cerone, M. & Smith, T. K., 20 Jul 2021, In: Frontiers in Nutrition. 8, 15 p., 570401.

    Research output: Contribution to journalReview articlepeer-review

  3. Organic light-emitting diodes as an innovative approach for treating cutaneous leishmaniasis

    Cabral, F. V., Lian, C., Persheyev, S., Smith, T. K., Ribeiro, M. S. & Samuel, I. D. W., 8 Jul 2021, (E-pub ahead of print) In: Advanced Materials Technologies. Early View, 9 p.

    Research output: Contribution to journalArticlepeer-review

  4. Towards chemical validation of Leishmania infantum ribose 5-phosphate isomerase as a drug target

    Dickie, E. A., Ronin, C., Sá, M., Ciesielski, F., Trouche, N., Tavares, J., Santarem, N., Major, L. L., Pemberton, I. K., MacDougall, J., Smith, T. K., Cordeiro-da-Silva, A. & Ciapetti, P., 19 Apr 2021, (E-pub ahead of print) In: Antimicrobial Agents and Chemotherapy. Early

    Research output: Contribution to journalArticlepeer-review

  5. Albumin-mediated alteration of plasma zinc speciation by fatty acids modulates blood clotting in type-2 diabetes

    Sobczak, A. I. S., Katundu, K. G. H., Phoenix, F. A., Khazaipoul, S., Yu, R., Lampiao, F., Stefanowicz, F., Blindauer, C. A., Pitt, S. J., Smith, T. K., Ajjan, R. A. & Stewart, A. J., 21 Mar 2021, In: Chemical Science. 12, 11, p. 4079-4093 15 p.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community

    Bezabih, Y. M., Sabiiti, W., Aalamneh, E., Bezabih, A., Peterson, G., Bezabhe, W. M. & Roujeinikova, A., 9 Oct 2020, (E-pub ahead of print) In: Journal of Antimicrobial Chemotherapy. Advance Article, 8 p., dkaa399.

    Research output: Contribution to journalReview articlepeer-review

  2. Can phenotypic data complement our understanding of antimycobacterial effects for drug combinations?

    Kloprogge, F., Hammond, R., Copas, A., Gillespie, S. H. & Della Pasqua, O., Dec 2019, In: Journal of Antimicrobial Chemotherapy. 74, 12, p. 3530–3536 7 p.

    Research output: Contribution to journalArticlepeer-review

  3. Protein binding of rifampicin is not saturated when using high-dose rifampicin

    Litjens, C. H. C., Aarnoutse, R. E., Van Ewijk-Beneken Kolmer, E. W. J., Svensson, E. M., Colbers, A., Burger, D. M., Boeree, M. J., te Brake, L. H. M. & PanACEA-MAMS-TB-01 Team, Apr 2019, In: Journal of Antimicrobial Chemotherapy. 74, 4, p. 986-990 5 p.

    Research output: Contribution to journalArticlepeer-review

  4. Comment on: Doxycycline in UK guidelines for hospital-acquired pneumonia

    Cevik, M., Russell, C. D. & Evans, M., 21 Feb 2019, In: Journal of Antimicrobial Chemotherapy. 74, 6

    Research output: Contribution to journalComment/debatepeer-review

  5. Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation

    Millard, J., Pertinez, H., Bonnett, L., Model, E. M., Dartois, V., Johnson, J. L., Caws, M., Tiberi, S., Bolhuis, M., Alffenaar, J-W. C., Davies, G. & Sloan, D. J., 23 Mar 2018, (E-pub ahead of print) In: Journal of Antimicrobial Chemotherapy. 73, 7, p. 1755-1762 8 p.

    Research output: Contribution to journalArticlepeer-review

ID: 6038249

Top